Business
Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar
(TheNewswire) Toronto, Ontario - The Newswire - November 24,  2023 - Ventripoint D...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario - The Newswire -\nNovember 24,  2023\n \n \n - Ventripoint Diagnostics\nLtd.\n \n \n (\"Ventripoint\"\nor the \"Company\"), (TSXV:VPT\n \n \n )\n \n \n (\n \n \n OTC:VPTDF)\n \n \n is pleased to announce that it will release its\nthird-quarter financial results and Management Discussion &\nAnalysis for 2023 on Wednesday, November 29, 2023, after close of\nmarket.  Ventripoint will host a webinar/conference call at 11:00\na.m. (EST) on Friday, December 1, 2023, to discuss its Q3 2023\nfinancial results and to provide an update on sales and marketing\nactivities.  Details of the webinar/conference call are as\nfollows:\n \n \n \n \n \n \n \n PARTICIPANT TELEPHONE NUMBERS\n \n \n \n \n \n \n \n \n \n \n Participant Link:\n \n \n \n \n \n \n https://www.c-meeting.com/web3/joinTo/3WYDHYDEHKKUTR/BmihFK6sSN8S7vZWzGGC2Q\n \n \n \n \n \n \n Alternatively, if participant does\nnot have Internet, please call:\n \n \n \n \n Canada/US Toll Free:\n1-844-763-8274\n \n \n \n \n \n \n \n \n Toronto Toll: +1-647-484-8814\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Please dial in 5 – 10 minutes prior to the scheduled\nstart time and simply ask to join the call.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac measurements\nequivalent to MRI. This affordable, gold-standard alternative allows\ncardiologists greater confidence in the management of their patients.\nProviding better care to patients serves as a springboard and basic\nstandard for all of Ventripoint's products that guide our future\ndevelopments. In addition, VMS+ is versatile and can be used with all\nultrasound systems from any vendor supported by regulatory market\napprovals in the U.S., Europe and Canada.  Learn more:\n www.ventripoint.com.\n \n \n \n \n For\n \n \n further information, please\nc...